Journal
JOURNAL OF FUNGI
Volume 6, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/jof6010021
Keywords
Candida; matrix; biofilm; immunity; drug resistance
Categories
Funding
- National Institutes of Health [R01AI073289, K08 AI108727]
- BurroughsWellcome Fund [1012299]
- Doris Duke Charitable Foundation [112580130]
Ask authors/readers for more resources
In healthcare settings, Candida spp. cause invasive disease with high mortality. The overwhelming majority of cases are associated with the use of critically-needed medical devices, such as vascular catheters. On the surface of these indwelling materials, Candida forms resilient, adherent biofilm communities. A hallmark characteristic of this process is the production of an extracellular matrix, which promotes fungal adhesion and provides protection from external threats. In this review, we highlight the medical relevance of device-associated Candida biofilms and draw attention to the process of Candida-biofilm-matrix production. We provide an update on the current understanding of how biofilm extracellular matrix contributes to pathogenicity, particularly through its roles in the promoting antifungal drug tolerance and immune evasion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available